A combination of demographic, regulatory and technological changes coupled with the current global scenario has created an inflection point for the Life Sciences industry in India.
With a record 140 million households likely to enter the middle class over the next few years merged with the governments thrust on universal healthcare through Ayushman Bharat and focus on local manufacturing via Atmanirbhar Bharat, the Life Sciences industry is expected to grow exponentially. The focus will be on new drug discovery, designing, engineering and manufacturing efficient medical devices, to providing new and enhanced patient experiences while adhering to low-costs and a rigid policy framework.
Indian pharma sector is projected to grow to US$ 100 billion by 2025, while the medical device market expected to touch US$ 25 billion within the same period. This when combined with government-led initiatives like 100% FDI for manufacturing of medical devices in India and the ‘Pharma Vision 2020’ document aimed at making India a global leader in end-to-end drug manufacture, makes the Life Sciences industry a highly lucrative segment.
In addition to drug discovery and medical device manufacturing, another area poised to take off is telemedicine with the National Health Stack (NHS); a virtual digital platform that will centralize all digital health records for Indian citizens by 2022 to make telemedicine and e-Health effortless.
In such a scenario, both life sciences and health personnel have become an integral part of our ecosystem, and the industry presents massive opportunities for all three sub-segments in the post-pandemic era.
Acing innovation in the industry
The World After: From Things to Life 2020 is a one-of-its-kind virtual conference that will provide in-depth insights into the vast potential of the Life Sciences sector in India. The event will cover numerous facets of the industry and provide insights into optimizing them to achieve complete transformation and meet diverse and elastic market demand.
The three essential sub-segments that the event will address are
- Medical device manufacturers – design, discovery, engineering to manufacturing
- Pharma & Biotech – rapid research on new molecules and drug discovery while adhering to regulatory compliance
- Patient Care: targeted solutions for personalized healthcare and improved patient outcomes
Addressing the business challenges of life science Industry, Dassault Systemes, will be demonstrating License to Cure for bio-pharma, ONE Lab, Collaborative Scientific Innovation, Accelerated Cure for Medical Devices Industry Solution Experiences based on the 3DEXPERIENCE platform.
Visionary speakers will address the event
Alongside these sessions the event features dedicated industry segment tracks led by brands like BIOVIA, SOLIDWORKS and SIMULIA. The 3DEXPERIENCE playground will showcases innovations on these brands and virtual experiences of technology demos of internet of things, artificial intelligence, machine leaning & data analytics applicable in the life sciences industry.
Register Now To Be Part Of The Most Innovative Life Sciences Event Of 2020
Date: June 23, 2020
Time: 9.30 AM – 12.30 PM
Location: The work desk @home (virtual conference)
click here to register for the event today.